Clinical Trials in Tennessee

Showing 17181-17200 of 20,239 trials

AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen

NCT00372788

The purpose of this study is to assess the effect and safety of AZD6244(ARRY-142886)versus pemetrexed in the second or third line treatment of advanced Non-Small Cell Lung Cancer. Following baseline assessments, a minimum of 64 patients in approximately 5-6 centers from the US will be treated with either AZD6244 or pemetrexed. Treatment will be continued for as long as patients receive clinical benefit.

Non-small Cell Lung Cancer

AstraZeneca88 participantsStarted Aug 2006

Los Angeles, California, United States • Ann Arbor, Michigan, United States • New York, New York, United States +5 more locations

COMPLETEDPhase 229 miles

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

NCT00372944

The purpose of this study is to assess the efficacy and safety of AZD6244 (ARRY-142886)versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line therapy with gemcitabine. Following baseline assessments, a minimum of 64 patients in approximately 5-6 centers from the US will be treated with either AZD6244 or capecitabine. Treatment will be continued for as long as the patients receive clinical benefit. The status of all patients will be checked (whether they are still taking treatment or not) approximately 3 months after the last patient has entered the study.

Pancreatic Cancer

AstraZeneca70 participantsStarted Aug 2006

Alhambra, California, United States • Bakersfield, California, United States • Palm Springs, California, United States +14 more locations

AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

Find Trials by Condition in Tennessee

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Study of Silodosin to Facilitate Passage of Urinary Stones

Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence

A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma

The CareFUL Prevention Trial

The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients

Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction

A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene